---
title: "Pro Fin Capital Services Ltd (511557) — Share Price, Financials & Analysis"
symbol: "511557"
company: "Pro Fin Capital Services Ltd"
canonical: "https://tapetide.com/stocks/511557"
isin: "INE732K01027"
nse_symbol: "PROFINCAPITALSERVICESLTD"
bse_code: "511557"
sector: "Commercial Services"
industry: "Diversified Services"
market_cap_cr: 146.92
generated_at: "2026-09-13T18:25:36.262Z"
---

# Pro Fin Capital Services Ltd (511557)

Canonical page: https://tapetide.com/stocks/511557

## Company

- **NSE Symbol:** PROFINCAPITALSERVICESLTD
- **BSE Code:** 511557
- **ISIN:** INE732K01027
- **Sector:** Commercial Services
- **Industry:** Diversified Services
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** profincapital.com

## About

Incorporated in 1991, Pro Fin Capital Services Ltd is engaged in financial sector and capital market services.

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:23.137271Z.

- **Market Cap:** ₹146.92 Cr
- **Classification:** Microcap
- **P/E (reported):** -62.5
- **EPS (TTM):** ₹-0.04
- **EPS (reported):** ₹0
- **Book Value:** ₹1.65
- **Price to Book:** 1.52
- **Dividend Yield:** 0%
- **ROE:** -29.73%
- **ROCE:** 3.34%
- **Debt to Equity:** 4.13
- **Revenue (yearly):** ₹20.3 Cr
- **Net Income:** ₹-7.1 Cr
- **EBITDA:** ₹8.3 Cr
- **52-Week High:** ₹7.64
- **52-Week Low:** ₹2.25
- **RSI (14):** 42.45

## Tapetide Score

- **Score:** 36 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 7.3 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 39.9 | 9% |
| growth | 2.64 | 9% |
| momentum | 10.64 | 12% |
| ownership | 49.7 | 24% |
| quality | 45.97 | 22% |
| valuation | 39.66 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding is low: 3.86%
- Company has a low return on equity of -0.03% over last 3 years.
- Company might be capitalizing the interest cost
- Promoters have pledged 33.3% of their holding.
- Promoter holding has decreased over last 3 years: -8.37%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 117.63% | — | — |
| ebitda margin growth | -46.15% | -10.94% | 592.27% | 767.16% |
| net income growth | -46.67% | -336.67% | -691.67% | 10% |
| revenue growth | -14.29% | -42.17% | 45% | 25% |
| roce | -44.68% | -51.52% | 39.17% | 4.47% |
| roe | -43.84% | -410.66% | -5.27% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4.23 | 5.7 | 5.84 | 8.85 | 6.97 | -32.11 | 8.95 | 10.52 | 42.61 | -8.23 | 16.98 | 36.76 |
| Expenses | 0.54 | 0.57 | 7.76 | 4.25 | 0.52 | 1.95 | 9.22 | 6.5 | 24.68 | 9.33 | 31.41 | 33.15 |
| Operating Profit | 3.69 | 5.13 | -1.92 | 4.6 | 6.45 | -34.06 | -0.27 | 4.02 | 17.93 | -17.56 | -14.43 | 3.61 |
| OPM % | 87.23 | 90 | -32.88 | 51.98 | 92.54 | — | -3.02 | 38.21 | 42.08 | — | -84.98 | 9.82 |
| Other Income | 0.13 | 0.13 | 0.13 | 0 | 0 | 0.4 | 0.15 | 0 | 2.01 | 0 | 7.79 | 0 |
| Interest | 2.82 | 4.2 | 2.8 | 2.8 | 3.01 | 2.67 | 2.89 | 0.57 | 0.82 | 0.23 | 0.93 | 0.25 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.01 | 0.06 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.92 | 0.98 | -4.67 | 1.73 | 3.37 | -36.4 | -3.02 | 3.39 | 19.12 | -17.79 | -7.57 | 3.36 |
| Tax % | 27.17 | 25.51 | -23.98 | 23.7 | 26.71 | 1.37 | -19.21 | 25.07 | 30.07 | -29.79 | -20.48 | 25.3 |
| Net Profit | 0.68 | 0.73 | -3.55 | 1.32 | 2.46 | -36.91 | -2.45 | 2.54 | 13.37 | -12.49 | -6.02 | 2.51 |
| EPS in Rs | 0.01 | 0.01 | -0.06 | 0.02 | 0.04 | -0.62 | -0.04 | 0.04 | 0.23 | -0.21 | -0.1 | 0.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 31.31 | 61.69 | 34.7 | 20.24 | 27.78 | 20.15 | 21.79 | 31.14 | 61.89 | 88.12 |
| Expenses | 28.44 | 58.27 | 18.88 | 11.91 | 8.5 | 6.75 | 9.56 | 15.09 | 71.92 | 98.57 |
| Operating Profit | 2.87 | 3.42 | 15.82 | 8.33 | 19.28 | 13.4 | 12.23 | 16.05 | -10.03 | -10.45 |
| OPM % | 9.17 | 5.54 | 45.59 | 41.16 | 69.4 | 66.5 | 56.13 | 51.54 | -16.21 | -11.86 |
| Other Income | 0 | 0.26 | 0.42 | 0.02 | 6.89 | 0.4 | 0.53 | 0.55 | 9.8 | 9.8 |
| Interest | 0.45 | 0.43 | 11.26 | 14.96 | 19.51 | 12.15 | 12.68 | 11.37 | 2.56 | 2.23 |
| Depreciation | 0.19 | 0.26 | 0.51 | 0.43 | 0.37 | 0.31 | 0.31 | 0.24 | 0.06 | 0 |
| Profit before tax | 2.23 | 2.99 | 4.47 | -7.04 | 6.29 | 1.34 | -0.23 | 4.99 | -2.85 | -2.88 |
| Tax % | 55.16 | 60.54 | 34.23 | 0.43 | 40.22 | 58.21 | 56.52 | 41.48 | -8.77 | — |
| Net Profit | 1 | 1.18 | 2.95 | -7.07 | 3.77 | 0.56 | -0.37 | 2.92 | -2.6 | -2.63 |
| EPS in Rs | 0.02 | 0.02 | 0.05 | -0.11 | 0.06 | 0.01 | -0.01 | 0.05 | -0.04 | -0.04 |
| Dividend Payout % | 0 | 5.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7.07 | 7.07 | 7.07 | 7.07 | 7.07 | 7.07 | 21.2 | 21.2 | 29.63 | 29.63 |
| Reserves | 17.21 | 18.54 | 20.16 | 23.77 | 16.7 | 31.51 | 18.11 | 7.66 | 40.83 | 38.23 |
| Borrowings | 11.6 | 13.64 | 115.71 | 197.66 | 213.92 | 252.73 | 280.09 | 315.64 | 298.82 | 280.55 |
| Other Liabilities | 54.33 | 105.25 | 79 | 42.55 | 37.54 | 15.3 | 30.03 | 17.95 | 7.21 | 41.35 |
| Total Liabilities | 90.21 | 144.5 | 221.94 | 271.05 | 275.23 | 306.61 | 349.43 | 362.45 | 376.49 | 389.76 |
| Fixed Assets | 0.62 | 0.42 | 6 | 5.5 | 5.07 | 22.43 | 22.12 | 21.8 | 21.57 | 17.77 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 4.15 | 4.4 | 4.42 | 11.44 | 11.47 | 5.21 | 5.21 | 5.21 | 5.21 | 3.29 |
| Other Assets | 85.44 | 139.68 | 211.52 | 254.11 | 258.69 | 278.97 | 322.1 | 335.44 | 349.71 | 368.7 |
| Total Assets | 90.21 | 144.5 | 221.94 | 271.05 | 275.23 | 306.61 | 349.43 | 362.45 | 376.49 | 389.76 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1.49 | -0.76 | -0.14 | -65.81 | 11.6 | -18.11 | -15.37 | -12.31 | -9.78 | 13.06 |
| Cash from Investing Activity | -0.64 | -0.25 | -5.85 | -7.02 | -11.04 | -11.47 | 0 | 0 | 0 | 7.49 |
| Cash from Financing Activity | 3.05 | 1.62 | 5.48 | 71.14 | 0.5 | 29.38 | 15.22 | 12.79 | 9.75 | -20.83 |
| Net Cash Flow | 0.92 | 0.6 | -0.51 | -1.69 | 1.07 | -0.2 | -0.15 | 0.47 | -0.03 | -0.28 |
| Free Cash Flow | -2.13 | -0.76 | -5.98 | -65.81 | 0.6 | -18.11 | -15.37 | -12.31 | -9.78 | 18.62 |
| CFO/OP | -53 | 3 | 20 | -409 | 153 | -85 | -76 | -93 | -61 | -138 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 0.35 | 0 | 0 | 0.36 | 0 | 0 | 0 | 0 | 47.48 |
| Inventory Days | 6.81 | 6.15 | 22.8 | 218.81 | 81.11 | 131.09 | 258 | — | 13.02 | 12.58 |
| Days Payable | 813.5 | 1425.44 | 288.43 | 161.77 | 281.93 | 194.83 | 72 | — | 0 | 185.33 |
| Cash Conversion Cycle | -806.69 | -1418.94 | -265.63 | 57.04 | -200.46 | -63.74 | 186 | 0 | 13.02 | -125.28 |
| Working Capital Days | 394.21 | 364.65 | -437.18 | -336.39 | -600.16 | -133.49 | -348.15 | -113.91 | -49.46 | -101.26 |
| ROCE % | 3.08 | 7.13 | 3.75 | 8.47 | 3.4 | 9.75 | 4.42 | 3.75 | 4.58 | -0.08 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 10.46% | 8.22% | 8.22% | 8.22% | 4.58% | 4.58% | 4.92% | 4.36% | 4.36% | 4.11% | 3.91% | 3.86% |
| FIIs | 0% | 0% | 0% | 0% | 0.47% | 0.24% | 0.34% | 0.34% | 0.3% | 0.02% | 0.02% | 0.02% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 79.92% | 83.72% | 83.32% | 85.47% | 86.25% | 90.66% | 88.7% | 89.51% | 88.93% | 88.79% | 77.01% | 74.94% |
| Others | 9.61% | 8.05% | 8.46% | 6.31% | 8.7% | 4.53% | 6.05% | 5.79% | 6.4% | 7.09% | 19.06% | 21.19% |
| No. of Shareholders | 23920 | 25054 | 25957 | 25863 | 27335 | 27996 | 26906 | 26663 | 27908 | 35044 | 36031 | 35340 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 5 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2.5 | Sell |
| EMA (10) | 2.5 | Sell |
| SMA (20) | 2.5 | Sell |
| EMA (20) | 2.54 | Sell |
| SMA (50) | 2.7 | Sell |
| EMA (50) | 2.72 | Sell |
| SMA (100) | 3.12 | Sell |
| EMA (100) | 3.02 | Sell |
| SMA (200) | 3.71 | Sell |
| EMA (200) | 3.35 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 43.31 | Neutral |
| MACD (12,26,9) | -0.06 | Buy |
| Stochastic (14,3,3) | 57.35 | Neutral |
| ADX (14) | 31.58 | Buy |
| Williams %R (14) | -45.45 | Neutral |
| ATR (14) | 0.15 | High Volatility |
| ROC (12) | 0.4 | Buy |
| Stoch RSI (14) | 86.84 | Sell |
| UO (7,14,28) | 68.01 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5c70c5e-b58b-41e4-bd41-9cc1348e30a1.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Conducting Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22ad8ac2-744e-446e-b19d-fcbed7a815b6.pdf) |
| 2026-08-31 | [Board Meeting Intimation for Conducting Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce03edc8-81e4-42d6-9166-c4dab2d32156.pdf) |
| 2026-08-18 | [Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b02f238-97d6-4856-87b9-761b8bf1d742.pdf) |
| 2026-08-12 | [Intimation About Adjournment Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=385ede5d-54d0-4424-9fcd-2feaa70e125d.pdf) |
| 2026-08-06 | [Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1af06e4-6ed9-44eb-9f09-4cab3f0f2e3d.pdf) |
| 2026-07-10 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa82e171-f8bf-4c82-b3eb-9cc2b4ced455.pdf) |
| 2026-07-06 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34aedfcb-2fb8-4035-b0a4-afbd7f28c4a1.pdf) |
| 2026-06-25 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=076167F5_6858_4391_A876_3FDDB841C1A3_140137.pdf) |
| 2026-06-25 | [Board Meeting Outcome for Increase In Authorized Share Capital Declined](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d2e337c-aec9-4a94-a19b-00aa97055c0c.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-18 | [Results: Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=664d0538-cac9-46cc-9d45-6f2c30561e34.pdf) |
| 2026-05-30 | [Results: Audited Financial Results For Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b229e0-91d4-4c8e-a0db-8fbdba223f23.pdf) |
| 2025-11-03 | [Result For The Quarter Ended September 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=443a1d8c-ca6c-453c-a798-673501e38326.pdf) |
| 2025-08-13 | [Result For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=442686f7-89a7-4666-abc8-f8fff3860485.pdf) |
| 2025-06-17 | [Results For The March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cbecf12-f58e-4600-9cd6-61b27ccbe2fc.pdf) |
| 2025-06-12 | [Result For The March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=782b6797-a0ea-4e21-a816-57f74b8e4fc8.pdf) |
| 2024-11-14 | [Results For The Quarter Ended 30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd782800-a0e3-450f-b15e-10fdd2d55775.pdf) |
| 2024-08-09 | [Outcome Of Board Meeting Held On 9Th August 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16380729-4ab9-40b0-98e0-2e2787441f8d.pdf) |
| 2024-05-30 | [Financial Result For The Quarter Ended On March 31 , 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edf6d273-9355-4a5e-8045-1079aa265695.pdf) |
| 2024-01-11 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On January 11, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9218a6f8-373e-40dc-b2f8-b64fd1e54c62.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 Feb - Board meeting on Feb 13, 2026 to approve unaudited Q3 December 2025 results with limited review. | [Board Meeting Intimation for Notice Of The Board Meeting 6 Feb - Board meeting on Feb 13, 2026 to approve unaudited Q3 December 2025 results with limited review.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4e08c87-27c9-4f79-a24f-89cc6d76572c.pdf) |
| 5 Jan - 1:1 bonus issue of 29,62,97,163 shares approved; post-capital 59,25,94,326; allotment approved Jan 5, 2026. | [Board Meeting Outcome for Outcome Of Borad Meeting For Allotment Of Bonus Issue Shares 5 Jan - 1:1 bonus issue of 29,62,97,163 shares approved; post-capital 59,25,94,326; allotment approved Jan 5, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a52862e8-71d2-4e82-93e2-5a087039bcd3.pdf) |
| 4 Feb - Investor meetings Feb 10 (Systematix, Taj Santacruz) and Feb 18 (Dolat Capital, Grand Hyatt), Mumbai; no UPSI. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Feb - Investor meetings Feb 10 (Systematix, Taj Santacruz) and Feb 18 (Dolat Capital, Grand Hyatt), Mumbai; no UPSI.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/514dd583-8b0e-424e-8c15-d1fc3d61c57e.pdf) |
| 2 Mar - Pinnacle Chile formed 100% owned Tripharma Chile SpA on Feb 27, 2026; CLP 1,000,000 share capital. | [Announcement under Regulation 30 (LODR)-Acquisition 2 Mar - Pinnacle Chile formed 100% owned Tripharma Chile SpA on Feb 27, 2026; CLP 1,000,000 share capital.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4c226f18-2a98-48b6-9637-355b28176d1f.pdf) |
| 1m - Investment in Pinnacle Life Science Private Limited, Wholly Owned Subsidiary of the Company | [Announcement under Regulation 30 (LODR)-Acquisition 1m - Investment in Pinnacle Life Science Private Limited, Wholly Owned Subsidiary of the Company](https://www.bseindia.com/xml-data/corpfiling/AttachLive/465b3082-49dc-4174-9260-42f178f1e4f2.pdf) |
| 19 Jan - Confirmation that securities dematerialised in quarter ended December 2025 were processed and registered within 15 days. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 19 Jan - Confirmation that securities dematerialised in quarter ended December 2025 were processed and registered within 15 days.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc12cae7-a0d7-4d39-891d-a16bdec4da89.pdf) |
| 17 Feb - Ramesh Sawalram Saraogi sold 83,00,000 Profin Capital shares on 16-Feb-2026; stake reduced to 12.49%. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 17 Feb - Ramesh Sawalram Saraogi sold 83,00,000 Profin Capital shares on 16-Feb-2026; stake reduced to 12.49%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/49DD047C_A792_4953_A8D8_6613454DB914_094312.pdf) |
| 16 Feb - Cancellation of Schedule of Analyst /Institutional Investor Meetings | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 16 Feb - Cancellation of Schedule of Analyst /Institutional Investor Meetings](https://www.bseindia.com/xml-data/corpfiling/AttachHis/042298f7-8196-48d5-9c58-b1bd5611532f.pdf) |
| 14h - Officials to attend Investec investor conference March 11, 2026, Trident BKC Mumbai, 10:00–14:00. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 14h - Officials to attend Investec investor conference March 11, 2026, Trident BKC Mumbai, 10:00–14:00.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9c36c9d3-aa63-4726-9bc1-e9bb84c1f5f2.pdf) |
| 10 Feb - Q3 & 9M FY26 Earning Conference Call Transcript | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 10 Feb - Q3 & 9M FY26 Earning Conference Call Transcript](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12526510-623f-4c1d-8698-a5cd5f755758.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8408530c-9a97-4c86-85e6-fe7ffbfdb4e9.pdf) |
| Sep 2024 | [Concall - Sep 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/abdd4481-cae9-423f-8863-9ba3db07a974.pdf) |
| Sep 2023 | [Concall - Sep 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/56c46cb6-18b8-46e9-a4a4-8cf689c836aa.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/91d689bc-6948-4c14-bee3-a0f6bc0affb1.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/059a00fe-b723-43f7-a070-601ab17a75d8.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1be6f5fc-e6b7-4807-832c-63ac97f90a7d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6fdf1955-f801-4102-86fd-a76096a0ec66.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73d2a789-50e0-4e6d-be3c-e60a66d443b4.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/617079fa-ec10-423d-9928-f7d3d1819bf9.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be128bae-e8ea-4eb9-9074-e07afaf24f88.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_AARTIDRUGS_2010_2011_21072011102556.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8fbfe419-cd84-4ea7-9e7c-9ff3639620bb.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f15eb4f7-dcab-430d-aba4-08befdd93e41.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4fa89774-ade3-4890-99b5-4acd99c28407.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70c25012-21bd-4524-9e79-74cdf0c4c4be.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/630ea7e6-109f-47fc-9c70-d756d219924d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c53a2ad0-f1cf-4776-9b87-b77b63785402.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524348/73635524348.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/511557/77144511557.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524348/69418524348.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:25:36.262Z.